These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29287224)

  • 1. The three betrayals of the medical cannabis growing activist: From multiple victimhood to reconstruction, redemption and activism.
    Klein A; Potter GR
    Int J Drug Policy; 2018 Mar; 53():65-72. PubMed ID: 29287224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global patterns of domestic cannabis cultivation: sample characteristics and patterns of growing across eleven countries.
    Potter GR; Barratt MJ; Malm A; Bouchard M; Blok T; Christensen AS; Decorte T; Frank VA; Hakkarainen P; Klein A; Lenton S; Perälä J; Werse B; Wouters M
    Int J Drug Policy; 2015 Mar; 26(3):226-37. PubMed ID: 25582281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes of cannabis growers to regulation of cannabis cultivation under a non-prohibition cannabis model.
    Lenton S; Frank VA; Barratt MJ; Dahl HV; Potter GR
    Int J Drug Policy; 2015 Mar; 26(3):257-66. PubMed ID: 25181993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the harms of cannabis cultivation in Belgium.
    Paoli L; Decorte T; Kersten L
    Int J Drug Policy; 2015 Mar; 26(3):277-89. PubMed ID: 25599596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propagating the Haze? Community and professional perceptions of cannabis cultivation and the impacts of prohibition.
    Beckett Wilson H; Taylor S; Barrett G; Jamieson J; Grindrod L
    Int J Drug Policy; 2017 Oct; 48():72-80. PubMed ID: 28810157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convenient labour: the prevalence and nature of youth involvement in the cannabis cultivation industry.
    Bouchard M; Alain M; Nguyen H
    Int J Drug Policy; 2009 Nov; 20(6):467-74. PubMed ID: 19345079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dangerous Drugs Act Amendment in Jamaica: Reviewing goals, implementation, and challenges.
    Davenport S; Pardo B
    Int J Drug Policy; 2016 Nov; 37():60-69. PubMed ID: 27596698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growing medicine: small-scale cannabis cultivation for medical purposes in six different countries.
    Hakkarainen P; Frank VA; Barratt MJ; Dahl HV; Decorte T; Karjalainen K; Lenton S; Potter G; Werse B
    Int J Drug Policy; 2015 Mar; 26(3):250-6. PubMed ID: 25123694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "The difference is in the tomato at the end": Understanding the motivations and practices of cannabis growers operating within Belgian Cannabis Social Clubs.
    Pardal M
    Int J Drug Policy; 2018 Jun; 56():21-29. PubMed ID: 29539581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Should I Buy or Should I Grow?" How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic.
    Belackova V; Maalsté N; Zabransky T; Grund JP
    Int J Drug Policy; 2015 Mar; 26(3):296-310. PubMed ID: 25655217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making residential cannabis growing operations actionable: a critical policy analysis.
    Carter C
    Int J Drug Policy; 2009 Jul; 20(4):371-6. PubMed ID: 19111455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why small-scale cannabis growers stay small: five mechanisms that prevent small-scale growers from going large scale.
    Hammersvik E; Sandberg S; Pedersen W
    Int J Drug Policy; 2012 Nov; 23(6):458-64. PubMed ID: 23036648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from conducting trans-national Internet-mediated participatory research with hidden populations of cannabis cultivators.
    Barratt MJ; Potter GR; Wouters M; Wilkins C; Werse B; Perälä J; Pedersen MM; Nguyen H; Malm A; Lenton S; Korf D; Klein A; Heyde J; Hakkarainen P; Frank VA; Decorte T; Bouchard M; Blok T
    Int J Drug Policy; 2015 Mar; 26(3):238-49. PubMed ID: 25576247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis social clubs in Belgium: organizational strengths and weaknesses, and threats to the model.
    Decorte T
    Int J Drug Policy; 2015 Feb; 26(2):122-30. PubMed ID: 25179934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-scale cannabis growers in Denmark and Finland.
    Hakkarainen P; Frank VA; Perälä J; Dahl HV
    Eur Addict Res; 2011; 17(3):119-28. PubMed ID: 21325852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The great cannabis classification debacle: what are the likely consequences for policing cannabis possession offences in England and Wales?
    Turnbull PJ
    Drug Alcohol Rev; 2009 Mar; 28(2):202-9. PubMed ID: 19320707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical Marijuana programs: implications for cannabis control policy--observations from Canada.
    Fischer B; Kuganesan S; Room R
    Int J Drug Policy; 2015 Jan; 26(1):15-9. PubMed ID: 25287942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growing practices and the use of potentially harmful chemical additives among a sample of small-scale cannabis growers in three countries.
    Lenton S; Frank VA; Barratt MJ; Potter GR; Decorte T
    Drug Alcohol Depend; 2018 Nov; 192():250-256. PubMed ID: 30292153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creating the cannabis user: a post-structuralist analysis of the re-classification of cannabis in the United Kingdom (2004-2005).
    Acevedo B
    Int J Drug Policy; 2007 May; 18(3):177-86. PubMed ID: 17689364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hashish in Morocco and Lebanon: A comparative study.
    Afsahi K; Darwich S
    Int J Drug Policy; 2016 May; 31():190-8. PubMed ID: 27178873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.